Heron Therapeutics Inc (NASDAQ:HRTX)

13.02
Delayed Data
As of Mar 03
 -0.31 / -2.33%
Today’s Change
6.51
Today|||52-Week Range
15.82
+29.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-7.3M-11.8M-23.3M-55.3M
 
 
 
 
 
Depreciation227.0K179.0K197.0K333.0K
 
 
 
 
 
Total Other Cash Flow1.9M2.4M5.0M11.4M
 
 
 
 
 
Funds From Operations-5.2M-9.3M-18.1M-43.5M
 
 
 
 
 
Funds From/For Other Operating Expenses267.0K-1.5M-1.1M-2.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.5M-7.7M-17.0M-40.8M
 
 
 
 
 
 
InvestingCapital Expenditures-78.0K-513.0K-972.0K-1.7M
 
 
 
 
 
Net Cash Flow Investing-78.0K-513.0K-972.0K-1.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.003.0M0.00
 
 
Long Term Borrowings0.001.3M0.000.00
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale77.0K22.8M50.5M61.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing77.0K24.1M53.5M61.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash-5.5M15.9M35.5M18.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account